MEDCEM PC and MTA in Pulpotomies of Primary Molars

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02291120

Enrollment

Registered

2014-11-14

Start date

2014-03-31

Completion date

2016-12-31

Last updated

2014-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.

Brief summary

The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MEDCEM PC and MTA when used as pulp dressings following pulpotomy in human primary molars.

Interventions

PROCEDUREPulpotomy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

3 Years to 10 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy children * molars showing: symptomless exposure of vital pulp by caries no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction) the possibility of proper restoration of the teeth no physiological resorption of more than one-third of the root

Exclusion criteria

* presence of systemic pathology * history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents

Design outcomes

Primary

Measure	Time frame	Description
Clinical success	24 months	No pain, no swelling, no fistula or sinus tract, no pathologic mobility
Radiographic success	24 months	No internal root resorption progressing into the bone, no external root resorption, no furcation and/or periapical bone destruction

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026